Meetings: National Cancer Institute
FR, April 22, 2010 › Notices › National Institutes of Health
Linked as:Text
Federal Register: April 22, 2010 (Volume 75, Number 77)
Notices
Page 21002-21003
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
DOCID:fr22ap10-64
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Drug Discovery, Chemoprevention and Targeted Therapy.
Date: May 25-27, 2010.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Peter J. Wirth, PhD, Scientific Review Officer,
Research Programs Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8129,
Bethesda, MD 20892-8328. 301-496-7565.pw2q@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Innovative and Early Stage Development of Emerging
Technologies in Biospecimen Science.
Date: June 14, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Page 21003
Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Donald L. Coppock, PhD, Scientific Review
Officer, Special Review and Logistic Branch, Division of Extramural
Activities, NCI, National Institutes of Health, 6116 Executive
Blvd., Rm 7151, Bethesda, MD 20892. 301-451-9385. donald.coppock@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, SPORE in Lymphoma and Breast Cancer.
Date: June 15-16, 2010.
Time: 5 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Shamala K. Srinivas, PhD, Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Boulevard,
Room 8123, Bethesda, MD 20892. 301-594-1224. ss537t@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: April 16, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
FR Doc. 2010-9312 Filed 4-21-10; 8:45 am
BILLING CODE 4140-01-P
Sponsored links
